Pfizer Long-Term Investments 2010-2024 | PFE

Pfizer long-term investments for the quarter ending September 30, 2024 were $11.148B, a 26.01% decline year-over-year.

  • Pfizer long-term investments for 2023 were $15.368B, a 1.98% increase from 2022.
  • Pfizer long-term investments for 2022 were $15.069B, a 30% decline from 2021.
  • Pfizer long-term investments for 2021 were $21.526B, a 6.24% increase from 2020.

Pfizer Long-Term Investments 2010-2024 | PFE

  • Pfizer long-term investments for 2023 were $15.368B, a 1.98% increase from 2022.
  • Pfizer long-term investments for 2022 were $15.069B, a 30% decline from 2021.
  • Pfizer long-term investments for 2021 were $21.526B, a 6.24% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$789.4B
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B